Table 2.

Response to IST with or without eltrombopag in children.

	Group A Pediatric patients with IST + EPAG (n = 15)	Group B Pediatric patients with IST only (n = 45)	P
3 months Response n (%)
Overall Response	8 (53.3)	21 (46.7)	0.655
CR	3 (20.0)	2 (4.4)	0.094
PR	5 (33.3)	19 (42.2)
NR	7 (46.7)	22 (48.9)
Off study	0 (0)	2 (4.4)
6 months Response n (%)
Overall Response	10 (66.7)	26 (57.8)	0.543
CR	7 (46.7)	6 (13.3)	0.012
PR	3 (20.0)	20 (44.4)
NR	5 (33.3)	14 (31.1)
Off study	0 (0)	5 (11.1)
12 months Response n (%)
Overall Response	10 (66.7)	32 (71.1)	0.754
CR	8 (53.3)	12 (26.7)	0.058
PR	2 (13.3)	20 (44.4)
NR	3 (20.0)	6 (13.3)
Off study	2 (13.3)	7 (15.6)

Note: EPAG, eltrombopag; IST, immunosuppressive therapy; CR, complete response; PR, partial response; NR, no response; OR, overall response.